Gallium-68 PSMA as an imaging agent in prostate cancer recurrence

A report in the Journal of Nuclear Medicine suggests that gallium-68 PSMA (68Ga-PSMA or [68Ga]PSMA) is better than an older radionuclide in detecting recurrent lesions in men with progressive prostate cancer after first-line therapy with surgery or radiation therapy. … READ MORE …

Radionuclide therapy with strontium-89 for relief of metastatic bone pain

A new article on the OncologySTAT web site provides a summary of a presentation by Alain Pecking, MD, from the annual meeting of the International Society for Geriatric Oncology. … READ MORE …